Soleus Capital Management »

Progyny shares owned by Soleus Capital Management

Quarter-by-quarter ownership of Progyny (PGNY) shares owned by Soleus Capital Management from 13F filings

Historical chart of Soleus Capital Management investment in Progyny

Tip: Access up to 7 years of quarterly data

All positions including Progyny held by Soleus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Progyny by Soleus Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $35M 2.1M 16.98

More positions owned by Soleus Capital Management

Krystal Biotech (KRYS)
Celcuity (CELC)
Tg Therapeutics (TGTX)
Insulet Corporation (PODD)
Novocure Ord Shs (NVCR)
United Therapeutics Corporation (UTHR)
Praxis Precision Medicines I Com New (PRAX)
Vericel (VCEL)
Alkermes SHS (ALKS)
Biosante Pharmaceuticals (ANIP)
Globus Med Cl A (GMED)
Geron Corporation (GERN)
Twist Bioscience Corp (TWST)
Edgewise Therapeutics (EWTX)
Beta Bionics (BBNX)

View all positions for Soleus Capital Management

Top funds holding Progyny

BlackRock
Vanguard Group
FMR
Vanguard Portfolio Management
State Street Corporation
Ameriprise Financial
Fort Washington Investment Advisors
Morgan Stanley
Wellington Management Company
Soleus Capital Management
Geode Capital Management
Dimensional Fund Advisors
Baillie Gifford & Co
Bank of America Corporation
Barclays

View all funds holding Progyny